[artículo]
| Título : |
Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients : A four-week, randomized, double-blinded, placebo-controlled study |
| Tipo de documento: |
texto impreso |
| Autores: |
Chongguan Ng, Autor ; Marco P.M. Boks, Autor ; Kit Roes, Autor |
| Fecha de publicación: |
2021 |
| Artículo en la página: |
pp. 491-498 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Metilfenidato, Depresión, Farmacoterapia, Mirtazapina, Paliativo, Cáncer |
| Resumen: |
This is a 4 week, randomized, double-blind, placebo-controlled study to examine the effects of methylphenidate as add-on therapy to mirtazapine compared to placebo for treatment of depression in terminally ill cancer patients. |
| Link: |
./index.php?lvl=notice_display&id=26968 |
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 491-498
|
Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.4 (Abril)
